Tuesday, 9th of September 2008 |
Reader feedback on our previous week's posting
‘In your recent posting you refer to hepatitis B vaccine as an "inexpensive vaccine". I would suggest that in countries such as the UK, somehow, this vaccine may still be relatively expensive and therefore making it seem relatively less cost-effective to introduce.
The Viral Hepatitis Prevention Board held a meeting in Edinburgh, United Kingdom, November 17-18, 2005 called "Can the United Kingdom control viral hepatitis?" Documents from this meeting are available at the organization's website(http://www.vhpb.org/). In a presentation on "economic aspects" which as we know, play an important part in decision making, it was interesting to see that the government's model was based
on the cost of a singe pediatric dose of hepatitis B vaccine (not including administration costs of seem to be an important part of 5 British pounds (almost 9 USD at that time). This translated to 35-40 times the UNICEF WAP price (below 0.25 USD at that time).
http://www.vhpb.org/files/html/Meetings_and_publications/Presentations/EDI36Edmundsweb.pdf
Perhaps it is time for lower prices even in richer countries so that all children can benefit from the first vaccine against cancer.
Regards
Steven Wiersma, MD, MPH
Medical Officer, Hepatitis Prevention
World Health Organization
Geneva, Switzerland
3) Free Online Training Materials
Hello All,
The Global Bureau of USAID has developed a series of short
(approximately two-hour), on-line courses on a variety of health
topics, including immunization. IMMUNIZATIONbasics contributed to the
preparation of the course called Immunization Essentials, which is
loosely patterned after the popular field guide by the same name.
To access the entire set of courses, including Immunization Essentials,
go to www.globalhealthlearning.org. A one-time, free registration is
required to access the courses.
(For ease of reference, the book Immunization Essentials itself is
available on our IMMbasics web site: www.immunizationbasics.jsi.com)
Robert Steinglass
IMMUNIZATIONbasics
Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
40561942 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |